Specialty
Aesthetics Cardiology Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Cardiology Interventional Radiology Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Search
Log In

Advice from the Experts: Novel Treatments and Case Discussions in nAMD & GA

By: Jennifer I. Lim, MD; Aleksandra V. Rachitskaya, MD

Webinar Credits: 1.0

Join Drs. Jennifer Lim and Aleksandra Rachitskaya as they discuss challenging cases of geographic atrophy and age-related macular degeneration, current treatments, and how investigative therapies may change the way patients with these conditions are managed in the future. A previously aired question-and-answer session will follow the presentation.

This certified CME activity is designed for retina specialists who manage patients with retinal diseases & other healthcare professionals involved in the management of patients with retinal diseases.

Expiration Date: Monday, January 31, 2022
Release Date: January 21, 2021

Learning Objectives

At the completion of this educational activity, you will be better able to:

  • Compare the challenges faced in management and treatment of patients in clinical practice and describe their impact on treatment outcomes.
  • Evaluate potential advantages of long-acting delivery options for wet AMD.
  • Interpret how novel pipeline candidates are being developed to address longer treatment intervals.

 

Accreditation and Designation Statement

This educational activity is provided by Evolve Medical Education LLC (Evolve).

Accreditation Statement
Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
Evolve designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Participation Method

In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

Course Viewing Requirements
Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS

Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+

 

Faculty and Disclosures


Jennifer I. Lim, MD
Marion H. Schenk Chair in Ophthalmology
Professor of Ophthalmology
Vice-Chair for Diversity & Inclusion
Director of the Retina Service
University of Illinois at Chicago
Chicago, Illinois


Aleksandra V. Rachitskaya, MD
Cole Eye Institute
Assistant Professor of Ophthalmology
Cleveland Clinic Lerner College of Medicine
Cleveland, Ohio

 

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Jennifer I. Lim, MD and or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Genentech, Regeneron, Novartis, Allergan, Cognition; Grant/Research Support: Genentech, Regeneron, Allergan, Stealth, Graybug, Chengdu Pharma; Data Monitoring Committee: Santen, Quark, Ophthea, Aura Bioscience; Speaker’s Bureau: Iveric Bio.

Aleksandra Rachitskaya, MD, and or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Allergan, Carl Zeiss Meditec, Novartis, and Regeneron Pharmaceuticals. Grant/Research Support: Genentech, and Novartis.

The Evolve staff and planners have no financial relationships with commercial interests.

Nisha Mukherjee, MD, peer reviewer, have no financial relationships with commercial interests.

 

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve.

 

Video Resources

BackNext

Test

Instructions

In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

Step 1 of 2

  • a. 1b. 2c. 3d. 4e. 5
  • AgreeNeutralDisagree
    Compare the challenges faced in management and treatment of patients in clinical practice and describe their impact on treatment outcomes.
    Evaluate potential advantages of long-acting delivery options for wet AMD.
    Interpret how novel pipeline candidates are being developed to address longer treatment intervals.
Back